 |
Video: What is a Stock Split?
|
 |
NanoViricides is a nano-biopharmaceutical research and development company focusing on the discovery, development, and commercialization of drugs for viral infections using its nanomedicines technology. Co.'s primary focus is bringing its anti-coronavirus drug into human clinical trials. Co.'s other programs include: NV-HHV-101 skin cream for treatment of shingles rash; and HerpeCide program, including skin creams for the treatment of genital ulcers, and for the treatment of cold sores. In addition, Co. has drug candidates in development against severe influenzas (including bird flu), human immunodeficiency virus, dengue, Ebola/Marburg and other viruses at different preclinical stages. According to our NNVC split history records, NanoViricides has had 1 split. | |
 |

NanoViricides (NNVC) has 1 split in our NNVC split history database. The split for NNVC took place on September 24, 2019. This was a 1 for 20 reverse split, meaning for each 20 shares of NNVC owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as NanoViricides conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the NNVC split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NanoViricides shares, starting with a $10,000 purchase of NNVC, presented on a split-history-adjusted basis factoring in the complete NNVC split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/07/2011 |
|
End date: |
03/04/2021 |
|
Start price/share: |
$26.00 |
|
End price/share: |
$4.65 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-82.12% |
|
Average Annual Total Return: |
-15.81% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,788.98 |
|
Years: |
10.00 |
|
|
 |
Date |
Ratio |
09/24/2019 | 1 for 20 |
|
 |